Leo Pharma to cut 200 jobs and reorganize

Danish Leo Pharma cuts down on staff in its global operations. Around 200 positions will be cut, while 50 will be moved to Poland.

By Saga Buskhe

October 10, 2024 2:11 PM

In recent years, things have gone well financially for the Danish dermatology company Leo Pharma. Despite this, staffing is now being cut. The reason, according to the company's CEO Cristophe Bourdon, is that it is far behind its competitors, reports Norwegian Medwatch.

Leo Pharma's reorganization mainly affects employees in Denmark. According to the Norwegian news site, 100 positions will be cut at the Danish headquarters in Ballerup. In total, around 200 positions will disappear and another 50 positions are planned to be moved to Poland.

– The company has undergone a transformation that has been ongoing since 2021, so what is happening now is a fairly natural next step. We are changing our innovation models a bit, similar to what other companies are doing now, says Anja Verhaug, Nordic General Manager, to the newspaper.

About Leo Pharma

Leo Pharma is a Danish company founded in 1908. The company develops treatments for skin diseases such as psoriasis and atopic eczema and has offices in several locations around the world. The company's research and development operations are located at the Danish head office in Ballerup.

Source: Leo Pharma

{{ comments.count === 1 ? '1 comment' : comments.count > 1 ? '{0} comments'.replace('{0}', comments.count) : 'Write a comment' }}

By submitting the comment you accept the terms. See terms

Good comment behavior

Keep a good tone in your comments, avoid personal attacks and posts of marketing character. Apply only link on your comment if it is relevant to the debate.

Be aware that the debates are moderated by the portal's editorial team.

The comment has been created.

Your comment will not be visible until you activate it. In a few moments you will receive an email where you must click on a link to activate your comment.